One last thing Maybe the anticipated relationship with Jansen will ensure PIQ gets the green light and stamp of FDA approval. The relationship with Jansen is probably our best insurance against any kind of unscrupulous dealings with the Federal Agency. Jansen really need Promarker D on board to justify future sales of their expensive new drug Canafloxin which slows kidney dysfunction in at risk diabetics. Phase 2 results are critical to this and it looks like the new hearing and results release will closely coincide with June 30. l think this is will get us across the line simple because big American Pharma has no limit of lobbying power stateside.
Cheers.
Ann: Proteomics files US FDA 513(g) regulatory submission, page-24
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
36.0¢ |
Change
0.005(1.41%) |
Mkt cap ! $58.86M | |||
| Open | High | Low | Value | Volume |
| 37.0¢ | 37.0¢ | 35.5¢ | $116.7K | 323.1K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 13166 | 35.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 37.0¢ | 113491 | 3 |
View Market Depth
| Last trade - 16.10pm 20/06/2025 (20 minute delay) ? |
| PIQ (ASX) Chart |